Annual D&A
$97.00 K
+$8000.00+8.99%
December 1, 2023
Summary
- As of February 10, 2025, NRSN annual depreciation & amortization is $97.00 thousand, with the most recent change of +$8000.00 (+8.99%) on December 1, 2023.
- During the last 3 years, NRSN annual D&A has risen by +$94.00 thousand (+3133.33%).
- NRSN annual D&A is now at all-time high.
Performance
NRSN Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
Quarterly D&A
N/A
September 1, 2024
Summary
- NRSN quarterly depreciation & amortization is not available.
Performance
NRSN Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Related metrics
TTM D&A
N/A
September 1, 2024
Summary
- NRSN TTM depreciation & amortization is not available.
Performance
NRSN TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Related metrics
NRSN Depreciation And Amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +9.0% | - | - |
| 3 y3 years | +3133.3% | - | - |
| 5 y5 years | - | - | - |
NRSN Depreciation And Amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +3133.3% | ||||
| 5 y | 5-year | at high | +3133.3% | ||||
| alltime | all time | at high | +3133.3% |
NeuroSense Therapeutics Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2024 | - | $11.00 K(+22.2%) | $11.00 K(+22.2%) |
| Dec 2023 | $97.00 K(+9.0%) | - | - |
| Jun 2023 | - | $9000.00 | $9000.00 |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2022 | $89.00 K(+2866.7%) | - | - |
| Jun 2022 | - | $41.00 K | $41.00 K |
| Dec 2021 | $3000.00(0.0%) | - | - |
| Dec 2020 | $3000.00 | - | - |
FAQ
- What is NeuroSense Therapeutics annual depreciation & amortization?
- What is the all time high annual D&A for NeuroSense Therapeutics?
- What is NeuroSense Therapeutics annual D&A year-on-year change?
- What is the all time high quarterly D&A for NeuroSense Therapeutics?
- What is the all time high TTM D&A for NeuroSense Therapeutics?
What is NeuroSense Therapeutics annual depreciation & amortization?
The current annual D&A of NRSN is $97.00 K
What is the all time high annual D&A for NeuroSense Therapeutics?
NeuroSense Therapeutics all-time high annual depreciation & amortization is $97.00 K
What is NeuroSense Therapeutics annual D&A year-on-year change?
Over the past year, NRSN annual depreciation & amortization has changed by +$8000.00 (+8.99%)
What is the all time high quarterly D&A for NeuroSense Therapeutics?
NeuroSense Therapeutics all-time high quarterly depreciation & amortization is $41.00 K
What is the all time high TTM D&A for NeuroSense Therapeutics?
NeuroSense Therapeutics all-time high TTM depreciation & amortization is $41.00 K